World’s First AI-Powered Ultrasound Robot Guides Successful Congenital Heart Defect Surgery
On the morning of September 5th, the Department of Cardiovascular Medicine at the Sixth Medical Center of the PLA General Hospital achieved a world first by successfully performing an interventional closure procedure for a congenital heart defect under the guidance of an AI-powered ultrasound robot. The patient, a 48-year-old man, was diagnosed with an atrial septal defect—a hole in the heart’s upper chambers—that had poor tissue margins, placing him in the high-difficulty category for minimally invasive surgery.
The operation was carried out by a team led by Dr. Zhu Hang, who collaborated with researchers from Tsinghua University to deploy their newly developed AI ultrasound robotic system. Unlike conventional interventional robots that only assist in delivering catheters or devices, this advanced system is capable of autonomously scanning the heart, identifying the lesion, generating real-time 3D anatomical models, and planning the optimal surgical path. This represents a major leap beyond the current robotic tools used in cardiac procedures, which are largely limited to mechanical assistance with instrument delivery.
Throughout the surgery, the robot provided continuous, precise navigation, allowing the team to guide a closure device to seal the defect with remarkable accuracy. The device was successfully implanted, and the procedure highlighted clear improvements in both safety and reproducibility over traditional techniques. By reducing dependence on manual imaging interpretation and steadiness of hand, the system could make such complex procedures more accessible to a broader range of clinical teams, especially those in remote areas with limited access to expert interventionalists.
This milestone is not just a technical feat but also a signal of a coming shift in how minimally invasive heart surgeries are performed globally. Experts note that while robotic systems have been used in cardiac procedures for several years, their role has mostly been as extends of the surgeon’s hands, not as intelligent partners capable of perception and decision-making. The Tsinghua-developed system, however, integrates machine vision and deep learning algorithms that allow it to interpret ultrasound images in real time and adjust its scanning patterns dynamically. This innovation is expected to push forward the development of fully autonomous robotic surgeries, where the machine could eventually execute entire procedures from start to finish under professional supervision.
The success of this operation also underscores the growing potential of AI in healthcare beyond diagnosis. With further refinements, such systems could standardize complex cardiac interventions, cut down surgery times, and decrease the radiation exposure associated with conventional imaging methods like fluoroscopy. In addition, because ultrasound carries no ionizing radiation, the combined use of AI and ultrasound may create safer environments for both patients and medical staff.
Looking ahead, Dr. Zhu’s team and Tsinghua’s engineers plan to refine the system through clinical trials across multiple Chinese hospitals. They also intend to explore its application to other cardiac conditions, such as valvular defects and certain rhythm disorders. As the technology matures, it may pave the way for semi-autonomous and eventually fully autonomous heart repair platforms, fundamentally transforming the current landscape of interventional cardiology. This first-in-human success marks a pioneering step, bringing the once speculative concept of intelligent robotic surgeons into tangible clinical reality.
